Martina Cirinciani
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Martina Cirinciani has a total of 18 co-authors. Here are the top co-authors by number of shared publications:
- Claudia Martini
Department of Pharmacy, University of Pisa, Via Bonanno 6, 56126 Pisa, Italy
2 shared publications - Alessia Pascazio
Department of Clinical and Experimental Medicine, University of Pisa, Pisa, 56126, Italy
1 shared publication Eleonora Da Pozzo
Department of Pharmacy, University of Pisa, via Bonanno 6, 56126 Pisa, Italy; Center for Instrument Sharing University of Pisa (CISUP), Lungarno Pacinotti, 43/44, 56126 Pisa, Italy
1 shared publication- Eleonora Da Pozzo
Department of Pharmacy, University of Pisa, Via Bonanno 6, 56126 Pisa, Italy
1 shared publication - Enrica Bonanni
Department of Clinical and Experimental Medicine, Neurology Unit, University of Pisa , Pisa
1 shared publication - Ferdinando Franzoni
Department of Clinical and Experimental Medicine, University of Pisa, 56126 Pisa, Italy
1 shared publication
Latest Publications
- 1 January 2026
- Published by Springer Nature in Molecular Neurobiology
- Vol. 63 (1)
Mild Cognitive Impairment Associated with Obstructive Sleep Apnoea: A Pilot Study on Oxygen-Related Plasma Biomarkers and Network Analysis
Obstructive sleep apnoea syndrome (OSAS) is a breathing disorder frequently associated with mild cognitive impairment (MCI), a potential prodromal stage of Alzheimer's disease (AD). However, the mechanisms underlying MCI in OSAS remain unclear, making the identification of early biomarkers crucial. This pilot study investigates biochemical parameters related to oxygen disturbance and AD in OSAS patients with and without MCI (OSAS + MCI and OSAS-MCI, respectively) and explores their interplay through a network-based analysis. A total of 45 subjects (30 OSAS patients; 15 healthy controls) were enrolled, undergoing clinical assessment, polygraphy, and blood sampling. Compared to controls, OSAS patients exhibited increased apnoea-hypopnea index, oxygen desaturation index, and the percentage of cumulative time with oxygen saturation below 90% during total sleep time (T90). Notably, in the entire OSAS cohort, T90 positively correlated with HIF-1α levels, which were higher than controls, although not significantly. Interestingly, both T90 and HIF-1α were elevated in OSAS + MCI patients compared to OSAS-MCI, confirming a positive correlation between their levels. Regarding AD-related biomarkers, t-Tau and p-Tau181 levels were elevated in OSAS + MCI. AUROC analysis demonstrated that HIF-1α and t-Tau had fair discriminative ability, whereas p-Tau181 showed good differentiation between OSAS + MCI and OSAS-MCI. Finally, a network-based analysis suggested HIF-1α as possible candidate player in disease pathways, potentially interacting with Tau phosphorylation via GSK-3β. These findings recommend HIF-1α, t-Tau, and p-Tau181 as possible peripheral candidates for early MCI detection in OSAS, pointing out their possible involvement in the pathogenesis of cognitive impairment in OSAS pathology.
- 1 January 2026
- Published by Springer Nature in Molecular Neurobiology
- Vol. 63 (1)
Mild Cognitive Impairment Associated with Obstructive Sleep Apnoea: A Pilot Study on Oxygen-Related Plasma Biomarkers and Network Analysis
Obstructive sleep apnoea syndrome (OSAS) is a breathing disorder frequently associated with mild cognitive impairment (MCI), a potential prodromal stage of Alzheimer's disease (AD). However, the mechanisms underlying MCI in OSAS remain unclear, making the identification of early biomarkers crucial. This pilot study investigates biochemical parameters related to oxygen disturbance and AD in OSAS patients with and without MCI (OSAS + MCI and OSAS-MCI, respectively) and explores their interplay through a network-based analysis. A total of 45 subjects (30 OSAS patients; 15 healthy controls) were enrolled, undergoing clinical assessment, polygraphy, and blood sampling. Compared to controls, OSAS patients exhibited increased apnoea-hypopnea index, oxygen desaturation index, and the percentage of cumulative time with oxygen saturation below 90% during total sleep time (T90). Notably, in the entire OSAS cohort, T90 positively correlated with HIF-1α levels, which were higher than controls, although not significantly. Interestingly, both T90 and HIF-1α were elevated in OSAS + MCI patients compared to OSAS-MCI, confirming a positive correlation between their levels. Regarding AD-related biomarkers, t-Tau and p-Tau181 levels were elevated in OSAS + MCI. AUROC analysis demonstrated that HIF-1α and t-Tau had fair discriminative ability, whereas p-Tau181 showed good differentiation between OSAS + MCI and OSAS-MCI. Finally, a network-based analysis suggested HIF-1α as possible candidate player in disease pathways, potentially interacting with Tau phosphorylation via GSK-3β. These findings recommend HIF-1α, t-Tau, and p-Tau181 as possible peripheral candidates for early MCI detection in OSAS, pointing out their possible involvement in the pathogenesis of cognitive impairment in OSAS pathology.
- 23 February 2024
- Published by Elsevier in Biochemical Pharmacology
- Vol. 228, 116078
Drug Mechanism: A bioinformatic update
- 23 February 2024
- Published by Elsevier in Biochemical Pharmacology
- Vol. 228, 116078
Drug Mechanism: A bioinformatic update